Evidence map›Paper›PMID 38089883›Full record

ArticleFrontiers in cell and developmental biology2023

Development of a contacting transwell co-culture system for the

Mayuko Nishi, Kensuke Tateishi, Jeremiah Stanleyraj Sundararaj, Yoko Ino, Yusuke Nakai, Yasuyoshi Hatayama, Yutaro Yamaoka, Yusaku Mihana, Kei Miyakawa, Hirokazu Kimura and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cell and developmental biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Mayuko NishiDepartment of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Kensuke TateishiDepartment of Neurosurgery, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Jeremiah Stanleyraj SundararajDepartment of Microbiology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Yoko InoAdvanced Medical Research Center, Yokohama City University, Yokohama, Japan.
Yusuke NakaiDepartment of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Yasuyoshi HatayamaDepartment of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Yutaro YamaokaDepartment of Microbiology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Yusaku MihanaDepartment of Microbiology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Kei MiyakawaDepartment of Microbiology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Hirokazu KimuraDepartment of Health Science, Gunma Paz University Graduate School of Health Sciences, Takasaki-shi, Japan.
Yayoi KimuraAdvanced Medical Research Center, Yokohama City University, Yokohama, Japan.
Tetsuya YamamotoDepartment of Neurosurgery, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Akihide RyoDepartment of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
National Institute of Infectious Diseases · JPYokohama City University · JPLife Science Institute · JPGumma Paz College · JPYokohama City University Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary central nervous system lymphoma (PCNSL) is a malignant neoplasm of the central nervous system that is refractory to treatment and has extremely poor prognosis. One factor hindering the development of therapeutic options for PCNSL is its molecular heterogeneity and the extreme difficulty in establishing

Indexed as

HGFlymphomaNFATNFkBPCNSLpericytesPin1vitrigel

Identifiers

PMID38089883
PMCPMC10712316
OpenAlexW4389035598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.